View Future GrowthTranslational Development Acquisition 過去の業績過去 基準チェック /46Translational Development Acquisition は平均年間 110.6% の収益成長を遂げていますが、Capital Markets 業界では年間 収益成長率 となっています。6.8% です。主要情報110.63%収益成長率93.67%EPS成長率Capital Markets 業界の成長10.26%収益成長率n/a株主資本利益率n/aネット・マージンn/a前回の決算情報31 Mar 2026最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Jul 29Translational Development Acquisition Corp. announced that it expects to receive $50 million in fundingTranslational Development Acquisition Corp. entered into subscription agreement to issue 5,000,000 Class A Ordinary Shares at an issue price of $10 per share for an aggregate gross proceeds of $50,000,000 on July 27, 2026. The company will also issue 5,000,000 Warrants at an exercise price of $11.50. The transaction include participation of new investor Naetas Holding Limited.ライブニュース • Jul 08ProLogium Advances De-SPAC Merger Process With TDAC After SEC F-4 FilingTranslational Development Acquisition announced that ProLogium has filed its initial Form F-4 registration statement with the SEC, a key step in progressing their planned de-SPAC merger. The F-4 filing provides the SEC and investors with more detailed information on ProLogium’s history and the proposed business combination, moving the transaction further along the regulatory process. TDAC units last traded at $11.60, with the stock down 27.2% over the past 30 days, indicating recent share price pressure despite the merger process advancing. This filing marks a formal point where investors can expect more comprehensive disclosures about ProLogium and the merger terms. These disclosures can help in assessing how the combined company might look and what deal risks remain, including regulatory review, shareholder approval, and any potential changes to the transaction structure.Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorates as stock falls 28%After last week's 28% share price decline to US$11.50, the stock trades at a trailing P/E ratio of 40.6x. Average trailing P/E is 40x in the Capital Markets industry in the US. Total returns to shareholders of 11% over the past year.お知らせ • May 29Prologium Holdings Inc. agreed to acquire Translational Development Acquisition Corp. (NasdaqGM:TDAC.U) from TDAC Partners LLC for approximately $3.8 billion in a reverse merger transaction.Prologium Holdings Inc. ntered into a definitive agreement to acquire Translational Development Acquisition Corp. (NasdaqGM:TDAC.U) from TDAC Partners LLC for approximately $3.8 billion in a reverse merger transaction on May 27, 2026. The transaction values Prologium at approximately $3.8 billion on a pre-money, net cash-free basis. Upon closing, ProLogium will own 92% of the combined company with SPAC & PIPE Investors owning 7%, and SPAC Sponsor owning 1%. Upon completion, the combined company is expected to be named ProLogium Technology and to be listed on Nasdaq under the ticker symbol "PRLG". As part of the transaction, the post-closing board shall consist of nine directors whom one individual is expected to be Michael Hoffman. The consummation of the transaction is conditioned upon, among other things: (i) approval for listing of Prologium Class A Ordinary Shares and warrants contemplated to be listed pursuant to the Business Combination Agreement on Nasdaq; (ii) the absence of any governmental order enjoining, restraining, prohibiting or otherwise making illegal the consummation of the Business Combination; (iii) receipt of the required approval by TDAC shareholders; (iv) receipt of the required approval by Prologium shareholders; (v) the effectiveness of the registration statement to be filed by Prologium under the Securities Act of 1933, as amended; (vi) the Second Merger Surviving Company, as successor to TDAC, having at least $5,000,001 of net tangible assets after the consummation of the Business Combination and the closing of any TDAC shareholder redemptions; (vii) completion of the Recapitalization in accordance with the Business Combination Agreement; (viii) lock-up agreement; (ix) registration rights agreement; and (x) Available Cash, as defined in the Business Combination Agreement, being greater than or equal to $250 million. The boards of directors of both ProLogium and TDAC have approved the Transaction, which is expected to close in the second half of 2026. Venable LLP acted as legal advisor for Translational Development Acquisition Corp. Sullivan & Cromwell LLP acted as legal advisor for Prologium Holdings Inc. BTIG, LLC acted as financial advisor for Translational Development Acquisition Corp. Cohen & Company Capital Markets, LLC acted as financial advisor for Prologium Holdings Inc. LCS & Partners acted as legal advisor for Prologium Holdings Inc.Board Change • May 26High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Chairman of the Board & CEO Michael M. Hoffman is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.お知らせ • Dec 24Translational Development Acquisition Corp. has completed an IPO in the amount of $150 million.Translational Development Acquisition Corp. has completed an IPO in the amount of $150 million. Security Name: Units Security Type: Equity/Derivative Unit Securities Offered: 15,000,000 Price\Range: $10 Discount Per Security: $0.55 Transaction Features: Blank Check Blind Pool Company収支内訳Translational Development Acquisition の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NasdaqGM:TDAC.U 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費31 Mar 26061031 Dec 25061030 Sep 25051030 Jun 25031031 Mar 25011031 Dec 24000030 Sep 240-11030 Jun 24000031 Mar 24000031 Dec 230000質の高い収益: TDAC.Uは 高品質の収益 を持っています。利益率の向上: TDAC.Uの 利益率 が過去 1 年間で改善したかどうかを判断するにはデータが不十分です。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: TDAC.Uの収益は過去 5 年間で年間110.6%増加しました。成長の加速: TDAC.Uの過去 1 年間の収益成長率 ( 339.7% ) は、5 年間の平均 ( 年間110.6%を上回っています。収益対業界: TDAC.Uの過去 1 年間の収益成長率 ( 339.7% ) はCapital Markets業界36.2%を上回りました。株主資本利益率高いROE: TDAC.Uの負債は資産を上回っているため、自己資本利益率を計算することは困難です。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YDiversified-financials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/07 17:20終値2026/07/28 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Translational Development Acquisition Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jul 29Translational Development Acquisition Corp. announced that it expects to receive $50 million in fundingTranslational Development Acquisition Corp. entered into subscription agreement to issue 5,000,000 Class A Ordinary Shares at an issue price of $10 per share for an aggregate gross proceeds of $50,000,000 on July 27, 2026. The company will also issue 5,000,000 Warrants at an exercise price of $11.50. The transaction include participation of new investor Naetas Holding Limited.
ライブニュース • Jul 08ProLogium Advances De-SPAC Merger Process With TDAC After SEC F-4 FilingTranslational Development Acquisition announced that ProLogium has filed its initial Form F-4 registration statement with the SEC, a key step in progressing their planned de-SPAC merger. The F-4 filing provides the SEC and investors with more detailed information on ProLogium’s history and the proposed business combination, moving the transaction further along the regulatory process. TDAC units last traded at $11.60, with the stock down 27.2% over the past 30 days, indicating recent share price pressure despite the merger process advancing. This filing marks a formal point where investors can expect more comprehensive disclosures about ProLogium and the merger terms. These disclosures can help in assessing how the combined company might look and what deal risks remain, including regulatory review, shareholder approval, and any potential changes to the transaction structure.
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorates as stock falls 28%After last week's 28% share price decline to US$11.50, the stock trades at a trailing P/E ratio of 40.6x. Average trailing P/E is 40x in the Capital Markets industry in the US. Total returns to shareholders of 11% over the past year.
お知らせ • May 29Prologium Holdings Inc. agreed to acquire Translational Development Acquisition Corp. (NasdaqGM:TDAC.U) from TDAC Partners LLC for approximately $3.8 billion in a reverse merger transaction.Prologium Holdings Inc. ntered into a definitive agreement to acquire Translational Development Acquisition Corp. (NasdaqGM:TDAC.U) from TDAC Partners LLC for approximately $3.8 billion in a reverse merger transaction on May 27, 2026. The transaction values Prologium at approximately $3.8 billion on a pre-money, net cash-free basis. Upon closing, ProLogium will own 92% of the combined company with SPAC & PIPE Investors owning 7%, and SPAC Sponsor owning 1%. Upon completion, the combined company is expected to be named ProLogium Technology and to be listed on Nasdaq under the ticker symbol "PRLG". As part of the transaction, the post-closing board shall consist of nine directors whom one individual is expected to be Michael Hoffman. The consummation of the transaction is conditioned upon, among other things: (i) approval for listing of Prologium Class A Ordinary Shares and warrants contemplated to be listed pursuant to the Business Combination Agreement on Nasdaq; (ii) the absence of any governmental order enjoining, restraining, prohibiting or otherwise making illegal the consummation of the Business Combination; (iii) receipt of the required approval by TDAC shareholders; (iv) receipt of the required approval by Prologium shareholders; (v) the effectiveness of the registration statement to be filed by Prologium under the Securities Act of 1933, as amended; (vi) the Second Merger Surviving Company, as successor to TDAC, having at least $5,000,001 of net tangible assets after the consummation of the Business Combination and the closing of any TDAC shareholder redemptions; (vii) completion of the Recapitalization in accordance with the Business Combination Agreement; (viii) lock-up agreement; (ix) registration rights agreement; and (x) Available Cash, as defined in the Business Combination Agreement, being greater than or equal to $250 million. The boards of directors of both ProLogium and TDAC have approved the Transaction, which is expected to close in the second half of 2026. Venable LLP acted as legal advisor for Translational Development Acquisition Corp. Sullivan & Cromwell LLP acted as legal advisor for Prologium Holdings Inc. BTIG, LLC acted as financial advisor for Translational Development Acquisition Corp. Cohen & Company Capital Markets, LLC acted as financial advisor for Prologium Holdings Inc. LCS & Partners acted as legal advisor for Prologium Holdings Inc.
Board Change • May 26High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Chairman of the Board & CEO Michael M. Hoffman is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Dec 24Translational Development Acquisition Corp. has completed an IPO in the amount of $150 million.Translational Development Acquisition Corp. has completed an IPO in the amount of $150 million. Security Name: Units Security Type: Equity/Derivative Unit Securities Offered: 15,000,000 Price\Range: $10 Discount Per Security: $0.55 Transaction Features: Blank Check Blind Pool Company